Double P53 Point Mutation in Extramedullar Blast Crisis of Chronic Myelogenous Leukemia

References

• Kurzrock R., Gutterman J. U., Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. N. Engl. J. Med. 1988; 319: 990–997
   PubMed Web of Science ®Google Scholar
• Daley G. Q., Van Etten R. A., Baltimore D. Induction of chronic myelogenous leukemia in mice by the p210 bcr-abl gene of the Philadelphia chromosome. Science 1990; 247: 824–830
   PubMed Web of Science ®Google Scholar
• Szczylyk C., Skorski T., Nicolaides N. C., Manzella L., Malaguamera L., Venturelli D., Gewirtz A. M., Calabretta B. Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides. Science 1991; 253: 562–565
   PubMed Web of Science ®Google Scholar
• Fleishman E. W., Prigogina E. L., Volkova M. A., Frenkell M. A., Zakhartehenko N. A., Kostantinova L. N., Pinchkova G. P., Balakirev S. A. Correlations between the clinical course, characteristics of blast cells and karyotype patterns in chronic myeloid leukemia. Human Genet. 1981; 58: 285–293
   PubMed Web of Science ®Google Scholar
• McBride O. W., Merry D., Givol D. The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17.13). Proc. Natl. Acad. Sci. USA 1986; 83: 130–134
   PubMed Web of Science ®Google Scholar
• Nakai H., Misawa S., Toguchida J., Yandell D. W., Ishizaki K. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p. Cancer Res. 1992; 52: 6588–6593
   PubMed Web of Science ®Google Scholar
• Schutte J., Opalka B., Becher R., Bardenheuer W., Szymanski S., Lux A., Seeber S. Analysis of the p53 gene in patients with isochromosome 17q and Phi-positive or negative myeloid leukemia. Leuk. Res. 1993; 17: 533–539
   PubMed Web of Science ®Google Scholar
• Ahuja H., Bar-Eli M., Advani S. H., Benchimol S., Cline M. J. Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proc. Natl. Acad. Sci. USA 1989; 86: 6783–6787
   PubMed Web of Science ®Google Scholar
• Kelman Z., Prokocimer M., Shoshana P., Kahn Y., Rechavi G., Manor Y., Cohen A., Rotter V. Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia. Blood 1989; 74: 2318–2324
   PubMed Web of Science ®Google Scholar
• Feinstein E., Cimino G., Gale R. P., Alimena G., Berthier R., Kishi K., Goldman J., Zaccaria A., Berrebi A., Canaani E. P53 in chronic myelogenous leukemia in acute phase. Proc. Natl. Acad. Sci. USA 1991; 88: 6293–6297
   PubMed Web of Science ®Google Scholar
• Mashal R., Shtalrid M., Talpaz M., Kantarjian H., Smith L., Beran M., Cork A., Trujillo J., Gutterman J., Deisseroth A. Rearrangement and expression of p53 in chronic phase and blast crisis of chronic myelogenous leukemia. Blood 1990; 75: 180–189
   PubMed Web of Science ®Google Scholar
• Ahuja H., Bar-Eli M., Zalmen A., Advani S., Allen S. L., Goldman J., Snyder D., Foti A., Cline M. The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia. J. Clin. Invest. 1991; 87: 2042–2047
   PubMed Web of Science ®Google Scholar
• Selleri L., Narni F., Emilia G., Colò A., Zucchini P., Venturelli D., Donelli A., Torelli U., Torelli G. Philadelphia-positive chronic myeloid leukemia with a chromosome 22 breakpoint outside the breakpoint cluster region. Blood 1987; 70: 1659–1664
   PubMed Web of Science ®Google Scholar
• Harlow E., Williamson N. M., Ralston R., Helfman D. M., Adams T. E. Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53. Mol. Cell. Biol. 1985; 5: 1601–1610
   PubMed Web of Science ®Google Scholar
• Orita M., Suzuki Y., Sekiya T., Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5: 874–879
   PubMed Web of Science ®Google Scholar
• Saiki R. K., Gelfand D. H., Stoffel S., Sharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487–491
   PubMed Web of Science ®Google Scholar
• Murakami Y., Hayashi K., Hirohashi S., Sekiya T. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res. 1991; 51: 5520–5525
   PubMed Web of Science ®Google Scholar
• Vogelstein B., Kinzler K. W. p53 function and dysfunction. Cell 1992; 70: 523–526
   PubMed Web of Science ®Google Scholar
• Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 1977; 74: 5463–5467
   PubMed Web of Science ®Google Scholar
• Lee J. S. Alternative dideoxy sequencing of double-stranded DNA by cyclic reactions using Taq polymerase. DNA Cell Biol. 1991; 10: 67–73
   PubMed Web of Science ®Google Scholar
• Harris C. C., Hollstein M. Clinical implications of the P53 tumor-suppressor gene. N. Engl. J. Med. 1993; 329: 1318–27
   PubMed Web of Science ®Google Scholar
• Hsu I. C., Metcalf R. A., Sun T., Welsh J. A., Wang N. J., Harris C. C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991; 350: 427–428
   PubMed Web of Science ®Google Scholar
• Bressac B., Kew M., Wands J., Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991; 350: 429–431
   PubMed Web of Science ®Google Scholar
• Hollstein M., Sidransky D., Vogelstein B., Harris C. C. p53 mutations in human cancers. Science 1991; 253: 49–53
   PubMed Web of Science ®Google Scholar
• Chang F., Syrjanen S., Tervahauta A., Syrjanen K. Tumorigenesis associated with the p53 tumor suppressor gene. Br. J. Cancer 1993; 68: 653–661
   PubMed Web of Science ®Google Scholar